Literature DB >> 34096874

Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey.

Katarina Braune1,2, Katarzyna Anna Gajewska3,4, Axel Thieffry5, Dana Michelle Lewis6, Timothée Froment7, Shane O'Donnell7, Jane Speight8,9, Christel Hendrieckx8,9, Jasmine Schipp8,10, Timothy Skinner8,10, Henriette Langstrup11, Adrian Tappe12, Klemens Raile1, Bryan Cleal13.   

Abstract

BACKGROUND: Automated insulin delivery (AID) systems have been shown to be safe and effective in reducing hyperglycemia and hypoglycemia but are not universally available, accessible, or affordable. Therefore, user-driven open-source AID systems are becoming increasingly popular.
OBJECTIVE: This study aims to investigate the motivations for which people with diabetes (types 1, 2, and other) or their caregivers decide to build and use a personalized open-source AID.
METHODS: A cross-sectional web-based survey was conducted to assess personal motivations and associated self-reported clinical outcomes.
RESULTS: Of 897 participants from 35 countries, 80.5% (722) were adults with diabetes and 19.5% (175) were caregivers of children with diabetes. Primary motivations to commence open-source AID included improving glycemic outcomes (476/509 adults, 93.5%, and 95/100 caregivers, 95%), reducing acute (443/508 adults, 87.2%, and 96/100 caregivers, 96%) and long-term (421/505 adults, 83.3%, and 91/100 caregivers, 91%) complication risk, interacting less frequently with diabetes technology (413/509 adults, 81.1%; 86/100 caregivers, 86%), improving their or child's sleep quality (364/508 adults, 71.6%, and 80/100 caregivers, 80%), increasing their or child's life expectancy (381/507 adults, 75.1%, and 84/100 caregivers, 84%), lack of commercially available AID systems (359/507 adults, 70.8%, and 79/99 caregivers, 80%), and unachieved therapy goals with available therapy options (348/509 adults, 68.4%, and 69/100 caregivers, 69%). Improving their own sleep quality was an almost universal motivator for caregivers (94/100, 94%). Significant improvements, independent of age and gender, were observed in self-reported glycated hemoglobin (HbA1c), 7.14% (SD 1.13%; 54.5 mmol/mol, SD 12.4) to 6.24% (SD 0.64%; 44.7 mmol/mol, SD 7.0; P<.001), and time in range (62.96%, SD 16.18%, to 80.34%, SD 9.41%; P<.001).
CONCLUSIONS: These results highlight the unmet needs of people with diabetes, provide new insights into the evolving phenomenon of open-source AID technology, and indicate improved clinical outcomes. This study may inform health care professionals and policy makers about the opportunities provided by open-source AID systems. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.2196/15368. ©Katarina Braune, Katarzyna Anna Gajewska, Axel Thieffry, Dana Michelle Lewis, Timothée Froment, Shane O'Donnell, Jane Speight, Christel Hendrieckx, Jasmine Schipp, Timothy Skinner, Henriette Langstrup, Adrian Tappe, Klemens Raile, Bryan Cleal. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 07.06.2021.

Entities:  

Keywords:  artificial pancreas; automated insulin delivery; diabetes; diabetes technology; digital health; do-it-yourself; medical device regulation; mobile health; motivation; online communities; open-source; patient-led; peer support; sleep quality; user-led

Year:  2021        PMID: 34096874     DOI: 10.2196/25409

Source DB:  PubMed          Journal:  J Med Internet Res        ISSN: 1438-8871            Impact factor:   5.428


  7 in total

Review 1.  Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals.

Authors:  Katarina Braune; Rayhan A Lal; Lenka Petruželková; Gary Scheiner; Per Winterdijk; Signe Schmidt; Linda Raimond; Korey K Hood; Michael C Riddell; Timothy C Skinner; Klemens Raile; Sufyan Hussain
Journal:  Lancet Diabetes Endocrinol       Date:  2021-11-13       Impact factor: 32.069

Review 2.  Automated insulin dosing systems: Advances after a century of insulin.

Authors:  Hood Thabit; Rayhan Lal; Lalantha Leelarathna
Journal:  Diabet Med       Date:  2021-09-28       Impact factor: 4.359

3.  Integrated Digital Health Solutions in the Management of Growth Disorders in Pediatric Patients Receiving Growth Hormone Therapy: A Retrospective Analysis.

Authors:  Vincenzo Tornincasa; David Dixon; Quentin Le Masne; Blaine Martin; Lilian Arnaud; Paula van Dommelen; Ekaterina Koledova
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-30       Impact factor: 6.055

Review 4.  Current Status and Emerging Options for Automated Insulin Delivery Systems.

Authors:  Gregory P Forlenza; Rayhan A Lal
Journal:  Diabetes Technol Ther       Date:  2022-03-14       Impact factor: 7.337

5.  Device activism and material participation in healthcare: retracing forms of engagement in the #WeAreNotWaiting movement for open-source closed-loop systems in type 1 diabetes self-care.

Authors:  Bianca Jansky; Henriette Langstrup
Journal:  Biosocieties       Date:  2022-04-22

6.  Emotional and Physical Health Impact in Children and Adolescents and Their Caregivers Using Open-source Automated Insulin Delivery: Qualitative Analysis of Lived Experiences.

Authors:  Katarina Braune; Niklas Krug; Christine Knoll; Hanne Ballhausen; Axel Thieffry; Yanbing Chen; Shane O'Donnell; Klemens Raile; Bryan Cleal
Journal:  J Med Internet Res       Date:  2022-07-14       Impact factor: 7.076

Review 7.  A scoping review of Do-It-Yourself Automated Insulin Delivery system (DIY AID) use in people with type 1 diabetes.

Authors:  Amy E Morrison; Kimberley Chong; Peter A Senior; Anna Lam
Journal:  PLoS One       Date:  2022-08-11       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.